Publication | Closed Access
Rivaroxaban, a factor Xa inhibitor, induces the secondary prevention of cardiovascular events after myocardial ischemia reperfusion injury in mice
26
Citations
24
References
2016
Year
InflammationThrombosisCardiovascular DiseaseMedicineSecondary PreventionCardiovascular PharmacologyCardiologyFactor Xa InhibitorPharmacotherapyReperfusion InjuryPharmacologyAtherosclerosisCardiovascular EventsAnesthesiology
| Year | Citations | |
|---|---|---|
Page 1
Page 1